Pharmaceutical and veterinary preparations for the treatment of the central nervous system, namely Alzheimer's disease, Parkinson's disease, Hungtington's disease, Pick's disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, stroke, ischaemia, epilepsy, brain injury, brain diseases, encephalitis, spinal cord injury, spinal cord diseases, cerebral paralysis, seizure disorders, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease and mood disorders, namely depression, schizophrenia and bipolar disorders; natural and synthetic bioactive preparations for application in the fields of human or animal medicine, namely pharmaceutical and veterinary preparations for the treatment of the central nervous system, namely Alzheimer's disease, Parkinson's disease, Hungtington's disease, Pick's disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, stroke, ischaemia, epilepsy, brain injury, brain diseases, encephalitis, spinal cord injury, spinal cord diseases, cerebral paralysis, seizure disorders, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease and mood disorders, namely depression, schizophrenia and bipolar disorders; intermediate pharmaceutical and veterinary preparations sold as components of pharmaceutical and veterinary preparations for the treatment of the central nervous system, namely Alzheimer's disease, Parkinson's disease, Hungtington's disease, Pick's disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, stroke, ischaemia, epilepsy, brain injury, brain diseases, encephalitis, spinal cord injury, spinal cord diseases, cerebral paralysis, seizure disorders, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease and mood disorders, namely depression, schizophrenia and bipolar disorders.

Scientific and industrial research, namely, regarding natural and synthetic bioactive preparations for application in the fields of human or animal medicine, agriculture, pesticides in general and cosmetics, and intermediate preparations in these fields of activity.

Human pharmaceuticals for the treatment of auto-immune diseases, cardiovascular diseases, central nervous system diseases and pain, namely Alzheimer's, Huntington's disease and cerebral palsy, dermatologic disorders, namely, dermatitis, skin pigmentation diseases and psoriasis, metabolic diseases, namely, diabetes, gout, arthritis and anemia, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases, anti-infective medications, anti-inflammatory medications, anti-viral medications and anti-pain medications; human pharmaceuticals for use as hemostatic agents.

Pharmaceutical preparations for the treatment of glaucoma.

Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases including metabolic disorders and diabetes; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology and hematology; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma or damage to the tissue or skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication.

Metal building materials, namely soffits and fascia; ceiling panels of metal; ceiling supports of metal; wall panels of metal; metal door panels; metal tiles; ceiling supports of metal; metal suspended ceiling systems comprising panels; metal cladding for construction and building; wall and ceiling linings of metal for building; grid system supports of metal for ceilings; lattices, runners, hangers, profiles, namely, building wall and ceiling framing primarily of metal, trims, splices, namely, metal connectors for walls, ceilings and grid systems, and clips of metal; parts and fittings of metal for all the aforesaid goods in this class in the nature of metal hardware, namely, washers, nuts, fastening anchors, bolts, rivets, screws, nails, spacer brackets, shelf brackets, and metal fittings, namely, metal joinery fittings, metal pipe fittings; transportable buildings of metal; metal building materials, namely, beams of metal, metal expansion joints for walls, construction elements of metal, namely, shores, supports and braces; tubes of metal; Building materials for sound absorbing, acoustic insulation and thermal insulation; architectural acoustic products, namely, sound absorbers and diffusers; mineral wool for use as a building insulation; glass wool, glass fiber and rock wool fiber for building and construction insulation; acoustic insulation barrier panels; building insulation; acoustic tiles; acoustical panels for building; insulating tiles; insulating structural panels for placement on edifices; metal foil for building insulation; fiberglass insulation for buildings; fiberglass fabric for building insulation; foam sheeting for use as a building insulation; foam insulation for use in building and construction; acrylic-based, silicone-based and urethane-based sealants; insulating paint; aerosol foam sealant and adhesives for construction particularly for use in glazing, siding and trim adhesive sealant and tape for industrial and commercial purposes; sealants for buildings; polyurethane film for use in sealing and insulating; polyurethane film for use as building insulation and as a moisture barrier; Non-metal building materials, namely, wall and ceiling boards, wall and ceiling panels, wall and ceiling tiles, soffits and fascia; non-metal fire-resistant boards and panels for construction; non-metal water-resistant boards and panels for construction; non-metal door panels; non-metal suspended ceiling systems comprising panels; non-metal ceiling panels; fireproof tiles; non-metal tiles; non-metal cladding for construction and building sheathing boards; construction material, namely, fiberglass faced; sheathing; wall systems, namely, movable, reusable, wall panels made primarily of nonmetal materials; Japanese style indoor sliding partitions not of metal; non-metal curtain walls; non-metal lattices, runners, hangers, profiles, namely, building wall and ceiling framing primarily of non-metal, trims, splices, namely, non-metal connectors for walls, ceiling and grid systems, and clips for suspended ceilings and walls; parts and fittings for all the aforesaid goods, namely, non-metal expansion joints for walls and ceiling, construction elements not made of metal, namely, shores, supports and braces; parts and fillings for all the aforesaid goods, namely, non-metal joinery fittings.

Processed food products and food ingredients namely cellulose gel, preservatives;

Fruits and vegetables; tofu, soy based products namely soymilk, milled soy, soy fibre, soy supplements, soy-based butter substitute, soy-based cheese substitute, and soy concentrates; soybeans; dairy products, namely milk, butter, cream, yoghurt, skim milk powder and whole milk powder; processed food products and food ingredients namely organic and natural frozen fruit, organic and natural frozen vegetables, fruit and vegetable concentrates, fruit and vegetable purees, fruit bars, grain based oils

Pharmaceutical and veterinary preparations for use in the treatment and prevention of cancer, metastases, oncological and cell-proliferative diseases, disorders and conditions; pharmaceutical preparations comprising platinum agents for use in the treatment of cancer.

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical antibodies for the treatment of cancer, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical antibodies for the treatment of the respiratory system; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervouse system stimulants; diagnostic pharmaceutical preparations used to increase heart rate and contrast imaging agents.

Implantable heart pacemakers and associated controller apparatus.